Jamal Smyej’s Post

Calling all data scientists and those interested in patient data! Don't miss out on this insightful webinar hosted by Datavant on May 21, 2024, at 1:00 p.m. EST. Dive into the world of artificial intelligence and its transformative impact on cancer patient outcomes. Register to secure your spot!

Calling all data scientists and those interested in patient data! Don't miss out on this insightful webinar hosted by Datavant on May 21, 2024, at 1:00 p.m. EST. Dive into the world of artificial intelligence and its transformative impact on cancer patient outcomes. Register to secure your spot!

Explore the journey of phData's client, a leading cancer research organization, as they revolutionized their data reporting system with the dynamic duo of Snowflake and Sigma Computing. Check out the success story today! 🏆 #casestudy #sucessstory #phdata #snowflake #sigma #datareporting

Hello everyone !! I am thrilled to share insights into the transformative world of cancer detection 🔺 and analysis through the lens of our comprehensive dashboard. 📶 In an era where data-driven decisions are paramount, this dashboard serves as a beacon of hope in the fight against cancer, offering actionable insights and facilitating informed medical interventions !!! 📈 📊 #Data Analysis using excel only !! 📊

AI does not eliminate the need for Cancer Registrars, their subject matter expertise, or human decision making capabilities. Rather, it automates, in real-time, routine data collection and puts at their fingertips information they might not see otherwise. Results may be used for clinical outcomes, business and strategic planning, performance improvement and more. This is the value-added component! E-Path Plus is a tool that makes this happen. Inspirata National Cancer Registrars Association (NCRA) Association of Cancer Executives

PathAI’s Ben Glass, VP of Product & Translational Research, will share his expertise later this month at the 31st International Precision Med TRI-CON. His featured panel session, Artificial Intelligence in Precision Oncology, will bring together thought leaders and experts from across the field to discuss emerging opportunities for investment, innovation and commercialization of AI-enabled technologies and solutions for precision oncology. #precisionmedicine #digitalpathology #precisiononcology #artificialintelligence

Think about all the manual, rote things you do as a healthcare professional, on repeat. Think about human error. Think about the quick way years of knowing and understanding cbcs, and how when you're teaching residents and fellows, all of the things that can be extrapolated. Now.. think about the sea of valuable information that we have not even scratched the surface on, as it relates to pharmacogenomics, how drugs effect people differently, and the troves of relation at the different steps of well known molecular pathways, and how we, to this date, act on 'retrospectively' to appreciate when and why something turned out.. to not work like we thought. And on top of that.. the reliance we trust our family's lives in, on the 'know' or 'yet to know' that exists inside the cranium of one individual making decisions on how long you or your loved one will remain in this world, and what the quality of that life looks like. Imagine... if we had a way to amass, aggregate, and unpack what we to date depend on individuals to 'come up with', theorize, test, figure out, and then re group. Oh, and we text with one adjustment or drug at a time... That's today. How do we leverage intelligence--magnitudes higher than what any human brain is able to do in its strongest best functioning hour--to make gains come sooner, for all those deserving. Get what's overdue, here. The lineup is nothing short, of an all in one.

Over the past 30 years, the Tri-Con has covered all aspects of cancer drug and diagnostic development. In the year of Artificial Intelligence, we are excited to offer a full day of sessions and panels addressing the impact of AI on Precision Oncology. Thank you to Douglas Flora, MD, LSSBB, FACCC for helping us organize. We look forward to hearing from thought leaders in the field, including Ezra Cohen, Scott Penberthy, Sanjay Juneja, M.D., Eric Stahlberg, Oscar Puig, Ben Glass, Arturo LoAIza-Bonilla MD, and Sean Khozin.   Please join Cambridge Healthtech Institute’s 31st International Precision Med TRI-CON, March 26-28, 2024 in San Diego. Visit www.triconference.com for detailed program and to register. Our last registration deadline is extended to tomorrow, plus you can use my code “LI200” for additional $200 discount. Look forward to seeing you in sunny San Diego! #precisionmedicine #ai #artificialintelligence #aiinhealthcare #aiinmedicine #aiinnovation #liquidbiopsy #genomics #personalizedmedicine #diagnostics #moleculardiagnostics #precisionhealth #digitalhealth #digitalmedicine #pointofcare #precisiononcology #ngs #circulatingtumorcells #cancerresearch #biomarkers #companiondiagnostics #immunooncology #spatialbiology #singlecell #raredisease #newbornsequencing #mced #earlydetection #genomicmedicine #innovation #cancerdiagnostics

Color Health uses GPT-4o's reasoning capabilities to help doctors transform cancer care. Cancer screening, diagnosis, and treatment delays can significantly impact patient outcomes. Color's AI copilot aims to expedite this process by helping clinicians identify missing tests and create comprehensive plans faster. By reducing the time to treatment initiation, this technology can potentially improve care efficiency and patient outcomes for the millions of people affected by cancer each year. https://lnkd.in/gAVc7gn3

Dr. Daniel Vorobiof, our Chief Medical Director, highlights the important role of Dave the AI Cancer Mentor in providing round-the-clock support to cancer patients and caregivers. Dave was created to, “optimize access to care for patients with cancer, reduce disparities, while providing a 24/7 coach to navigate the difficult care path, GPS style.” This article is a response to a piece by Anant Madabhushi Jame Abraham, M.D. FACP on AI advancements in cancer care, including ways to reduce disparities and address social determinants of health. Dr. Vorobiof's insights follow our recent ASCO abstract highlighting a multi-institutional report showing that Dave provides valuable and reliable recommendations, achieving nearly 92% positive validation. Read more about it: https://lnkd.in/dFSFBMhy ASCO Abstract:  https://lnkd.in/dStYEQfi